NCT06877104 Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression
| NCT ID | NCT06877104 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Depression, Postpartum |
| Study Type | INTERVENTIONAL |
| Enrollment | 156 participants |
| Start Date | 2025-03-13 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 156 participants in total. It began in 2025-03-13 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.
Eligibility Criteria
Inclusion Criteria: * Postpartum patients who have delivered a singleton baby at or after 37w0d at the Hospital of the University of Pennsylvania * Self-identify as a person of color (listed on chart as non-White race and confirmed with patient) * Able to speak, read and write English * Age ≥18 * Prenatal care at outpatient practice affiliated with the Hospital of the University of Pennsylvania * Completion of clinically administered EPDS during inpatient stay * Routine discharge timing, day 2 or more after vaginal delivery, day 3 or more after cesarean delivery Exclusion Criteria: * Unable to provide informed consent * Baby not discharged with mother at postpartum discharge * Does not have access to a mobile phone
Contact & Investigator
Kirstin Leitner, MD
PRINCIPAL INVESTIGATOR
University of Pennsylvania
Frequently Asked Questions
Who can join the NCT06877104 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Depression, Postpartum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06877104 currently recruiting?
Yes, NCT06877104 is actively recruiting participants. Contact the research team at meaghan.mccabe@pennmedicine.upenn.edu for enrollment information.
Where is the NCT06877104 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06877104 clinical trial?
NCT06877104 is sponsored by University of Pennsylvania. The principal investigator is Kirstin Leitner, MD at University of Pennsylvania. The trial plans to enroll 156 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.